Everolimus for Treating Pediatric Patients With Recurrent or Refractory Tumors

NCT00187174 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

41

Enrollment

OTHER

Sponsor class

Conditions

Tumors
Brain Tumors
Rhabdomyosarcoma
Sarcoma, Soft Tissue

Interventions

DRUG: Everolimus

Sponsor

St. Jude Children's Research Hospital

Collaborators

[object Object]